Amicogen Market Cap

Amicogen has a market cap or net worth of 132.80 billion as of April 29, 2026. Its market cap has decreased by -31.27% in one year.

Market Cap

132.80B

Enterprise Value

231.64B

Revenue

41.98B

Ranking

n/a

PE Ratio

n/a

Stock Price

1,885.00

Market Cap Chart

Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 132.80B, a decrease of -44.01%. That is a compound annual growth rate of -4.49%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	133.16B	34.57%
Dec 30, 2025	98.95B	-53.23%
Dec 30, 2024	211.59B	-48.65%
Dec 28, 2023	412.06B	8.63%
Dec 29, 2022	379.32B	-38.89%
Dec 30, 2021	620.70B	-14.98%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
iNtRON Biotechnology	119.66B
Oncocross	107.81B
CG Invites	101.50B
IMB Dx	101.21B
ENCell	181.64B
Vaxcell-Bio Therapeutics	182.57B
Macrogen	183.22B
MedPacto	188.17B

Market Cap Rankings